Literature DB >> 16919782

Adjuvant and immunostimulatory effects of beta-glucan administration in combination with lipopolysaccharide enhances survival and some immune parameters in carp challenged with Aeromonas hydrophila.

V Selvaraj1, K Sampath, Vaithilingam Sekar.   

Abstract

Combined effects of beta-glucan and lipopolysaccharide (LPS) on survival and immune response were studied in Cyprinus carpio that were challenged with the pathogen Aeromonas hydrophila. beta-Glucan from Saccharomyces cervisiae and LPS from a virulent strain of A. hydrophila were used in this study. Different concentrations of beta-glucan+LPS mixture were administered on days 1, 7, and 14 through different routes (intraperitoneal injection, bathing, and oral administration). Control and test fish were challenged by intraperitoneal injection of LD50 concentration of A. hydrophila on day 16 and subsequently, mortality and relative percent survival (RPS) were recorded. Intraperitoneal injection elicited 100% RPS even at the lowest concentration (100 microg beta-glucan+10 microg LPS); whereas, oral administration improved RPS rate of carps at higher concentration (1% beta-glucan+0.25% LPS). Bathing did not improve the RPS. Test animals injected with even the minimum dose of the immunomodulators (100 microg beta-glucan+10 microg LPS/fish) had a significant increase in total blood leukocyte counts and an increase in the proportion of neutrophils and monocytes. Superoxide anion production by macrophages was also elevated, which presumably aided the efficient killing of bacterial pathogen. Lower concentration of beta-glucan+LPS had an adjuvant effect on antibody production as pretreatment by injection of 100 microg beta-glucan+10 microg LPS/fish resulted in higher antibody titer against A. hydrophila following vaccination. RT-PCR analyses showed that the expression of interleukin-1beta mRNA did not increase in test fish when compared with the control. Classical and alternative complement pathways were not affected by either the dose or the route of administration of the compounds. It may be concluded that intraperitoneal injection and oral administration, and not the bathing, of beta-glucan+LPS mixture in carp could enhance resistance to challenge by A. hydrophila through changes in several non-specific and specific immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919782     DOI: 10.1016/j.vetimm.2006.06.011

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

Review 1.  Beta-glucan: an ideal immunostimulant in aquaculture (a review).

Authors:  D K Meena; Pronob Das; Shailesh Kumar; S C Mandal; A K Prusty; S K Singh; M S Akhtar; B K Behera; Kundan Kumar; A K Pal; S C Mukherjee
Journal:  Fish Physiol Biochem       Date:  2012-09-11       Impact factor: 2.794

2.  Effects of dietary β-1,3/1,6-glucan on the antioxidant and digestive enzyme activities of Pacific red snapper (Lutjanus peru) after exposure to lipopolysaccharides.

Authors:  Laura T Guzmán-Villanueva; Felipe Ascencio-Valle; María E Macías-Rodríguez; Dariel Tovar-Ramírez
Journal:  Fish Physiol Biochem       Date:  2013-11-26       Impact factor: 2.794

3.  Secondary Metabolites of Antarctic Fungi Antagonistic to Aquatic Pathogenic Bacteria.

Authors:  Huibin Zhao; Chuner Cai; Xiaoyu Liu; Binghua Jiao; Bo Chen; Menghao Cai; Peimin He
Journal:  Open Life Sci       Date:  2018-03-20       Impact factor: 0.938

4.  A Novel Ex Vivo Approach Based on Proteomics and Biomarkers to Evaluate the Effects of Chrysene, MEHP, and PBDE-47 on Loggerhead Sea Turtles (Caretta caretta).

Authors:  Laura Bianchi; Silvia Casini; Lorenza Vantaggiato; Agata Di Noi; Alfonso Carleo; Enxhi Shaba; Alessandro Armini; Francesco Bellucci; Giovanni Furii; Luca Bini; Ilaria Caliani
Journal:  Int J Environ Res Public Health       Date:  2022-04-05       Impact factor: 3.390

Review 5.  An Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for Finfish.

Authors:  Hetron Mweemba Munang'andu; Stephen Mutoloki; Øystein Evensen
Journal:  Front Immunol       Date:  2015-10-22       Impact factor: 7.561

Review 6.  Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.

Authors:  Oliver Pérez; Belkis Romeu; Osmir Cabrera; Elizabeth González; Alexander Batista-Duharte; Alexis Labrada; Rocmira Pérez; Laura M Reyes; Wendy Ramírez; Sergio Sifontes; Nelson Fernández; Miriam Lastre
Journal:  Front Immunol       Date:  2013-12-02       Impact factor: 7.561

7.  Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms.

Authors:  Débora Torrealba; Joaquin Seras-Franzoso; Uwe Mamat; Kathleen Wilke; Antonio Villaverde; Nerea Roher; Elena Garcia-Fruitós
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

Review 8.  Development of Fish Immunity and the Role of β-Glucan in Immune Responses.

Authors:  Marianna V Rodrigues; Fábio S Zanuzzo; João Fernando A Koch; Carlos Alberto F de Oliveira; Petr Sima; Vaclav Vetvicka
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

9.  GAS1: A New β-Glucan Immunostimulant Candidate to Increase Rainbow Trout (Oncorhynchus mykiss) Resistance to Bacterial Infections With Aeromonas salmonicida achromogenes.

Authors:  Valérie Cornet; Trinh Dinh Khuyen; Syaghalirwa N M Mandiki; Stéphane Betoulle; Peter Bossier; Felipe E Reyes-López; Lluis Tort; Patrick Kestemont
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.